About Michael Morton

Dr Michael Morton PhD. A co-founder of ApconiX, Mike is an expert electrophysiologist and ion channel biologist with extensive experience gained in academia and industry. Mike’s career has spanned pure research, ion channel assay development and large-scale screening of all manner of ligand- and voltage-gated ion channels. Mike learned his craft as a postdoctoral fellow first at Leeds (with Malcolm Hunter) then at Yale (with Fred Sigworth) before joining the global ion channel initiative at AstraZeneca where his skills were applied to drug projects. Mike has a serious passion for ion channels and enjoys working with collaborators and clients alike to ensure the highest quality data are used to support better decision-making.

The Reductionist Approach

The Reductionist Approach The hERG assay has been a mainstay of safety screening in drug discovery for the last 2 decades. Aided by the development of high throughput automated technology, this important assay has brought unparalleled progress in our ability to design safer drugs without those properties that may lead to [...]

By |2021-08-13T13:44:03+01:00July 11th, 2019|Ion Channels|Comments Off on The Reductionist Approach

ApconiX Welcomes Priscilla Dumenu

ApconiX Welcomes Priscilla Dumenu ApconiX is delighted to welcome Priscilla Dumenu for a 2-week placement.  Priscilla will be working alongside Dr Michael Morton and Dr Karen Jones in the Ion Channel laboratory. Priscilla has just finished her second year studying Pharmacy at the University of Manchester.  The 5-year integrated master’s degree [...]

By |2021-08-13T13:46:56+01:00June 28th, 2019|Careers, Ion Channels|Comments Off on ApconiX Welcomes Priscilla Dumenu

ApconiX Welcomes Rosie Tennant

ApconiX Welcomes Rosie Tennant ApconiX is delighted to welcome Rosie Tennant, who joins us for work experience this week.  Rosie will be working with Dr Michael Morton and Dr Karen Jones in the ion channel laboratory. Rosie is in Year 12 at The Fallibroome Academy, a secondary and sixth form college [...]

By |2022-02-15T14:28:07+00:00June 14th, 2019|Careers|Comments Off on ApconiX Welcomes Rosie Tennant

Sophion’s Ion Channel Modulation Symposium

Sophion’s Ion Channel Modulation Symposium Dr Michael Morton will be attending Sophion’s Ion Channel Modulation Symposium, on the 19th to 20th of June 2019, at Clare College in Cambridge, UK. Sophion was founded almost twenty years ago by a group of passionate electrophysiologists and offers the some of the [...]

By |2024-02-19T10:38:32+00:00June 12th, 2019|Events, Ion Channels|Comments Off on Sophion’s Ion Channel Modulation Symposium

ApconiX Joins the MDC’s Virtual R&D platform

ApconiX Joins the MDC’s Virtual R&D platform ApconiX has joined the Medicines Discovery Catapult’s Virtual R&D platform.  This is a unique national network of consultants, private sector CROs, expert labs and public sector centres of excellence, providing medicines discovery expertise, services and virtual programme management. ApconiX specialises in ion [...]

By |2022-02-22T12:48:05+00:00June 6th, 2019|Ion Channels|Comments Off on ApconiX Joins the MDC’s Virtual R&D platform

ApconiX Welcomes Sushma Pabbineedi.

ApconiX Welcomes Sushma Pabbineedi. ApconiX is delighted to welcome Sushma Pabbineedi for a placement during May.  Sushma will be working alongside Dr Michael Morton and Dr Karen Jones in the ion channel laboratory. Sushma studied Biomedical Sciences and gained a bachelor’s degree from Manchester Metropolitan University.  She took a [...]

By |2022-02-22T12:55:17+00:00May 9th, 2019|Ion Channels, Careers|Comments Off on ApconiX Welcomes Sushma Pabbineedi.

K2p3.1 protein is expressed as a transmural gradient across the rat left ventricular free wall

K2p3.1 protein is expressed as a transmural gradient across the rat left ventricular free wall Dr Michael Morton co-authored a paper recently published in the Journal of Cardiovascular Electrophysiology. The paper should serve as a reminder that ion channels which may not be the focus of regulatory guidance or [...]

By |2022-02-22T13:07:39+00:00April 18th, 2019|Ion Channels, Publications|Comments Off on K2p3.1 protein is expressed as a transmural gradient across the rat left ventricular free wall

SOT 58th Annual Meeting & ToxExpo – 2588: Talk by Dr Michael Morton of ApconiX

SOT 58th Annual Meeting & ToxExpo - 2588: Talk by Dr Michael Morton of ApconiX At the Society of Toxicology 58th Annual Meeting and ToxExpo from March 10th to 14th at the Baltimore Convention Center, Dr Michael Morton of ApconiX will be giving a talk as part of the workshop [...]

By |2024-03-20T14:01:11+00:00March 6th, 2019|Ion Channels, Events|Comments Off on SOT 58th Annual Meeting & ToxExpo – 2588: Talk by Dr Michael Morton of ApconiX

SOT 58th Annual Meeting & ToxExpo – 2072: Poster Presentation by Richard Printemps of PhysioStim

SOT 58th Annual Meeting & ToxExpo - 2072: Poster Presentation by Richard Printemps of PhysioStim At the Society of Toxicology 58th Annual Meeting and ToxExpo from March 10th to 14th at the Baltimore Convention Center, poster presentation by Richard Printemps of PhysioStim on Tuesday March 12th 3:00pm - 4:30pm Poster [...]

By |2024-03-20T14:02:14+00:00March 5th, 2019|Ion Channels, Events|Comments Off on SOT 58th Annual Meeting & ToxExpo – 2072: Poster Presentation by Richard Printemps of PhysioStim

ApconiX Welcomes Dr Steffen Ernst

ApconiX Welcomes Dr Steffen Ernst ApconiX is delighted to welcome Dr Steffen Ernst to our team, as the company begins its international expansion with the formation of its Swedish subsidiary, ApconiX AB. Steffen has worked in preclinical and clinical safety for over 20 years with Hoechst-Schering, Boehringer-Ingelheim, AstraZeneca, Pfizer [...]

By |2022-12-13T17:54:05+00:00February 6th, 2019|Toxicology, Careers|Comments Off on ApconiX Welcomes Dr Steffen Ernst
Go to Top